Recombinant TAG-72 (Minretumomab Biosimilar) 抗体
This anti-TAG-72 (Minretumomab Biosimilar) antibody is a 小鼠 单克隆 antibody detecting TAG-72 (Minretumomab Biosimilar) in FACS, IHC, RIA 和 WB. Suitable for 人.
1 image
Quick Overview for Recombinant TAG-72 (Minretumomab Biosimilar) 抗体 (ABIN7072523)
抗原
TAG-72 (Minretumomab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
小鼠
克隆类型
单克隆
标记
This TAG-72 (Minretumomab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), Immunohistochemistry (IHC), Radioimmunoassay (RIA), Western Blotting (WB)
-
-
原理
- Anti-TAG-72 [Minretumomab (CC49 )], Mouse IgG1, kappa
-
特异性
- This antibody is specific for the disaccharide sialyl Tn epitope of human TAG-72. TAG-72 is expressed on a wide range of human carcinomas, including colorectal cancers.
-
产品特性
-
Original Species of Ab: Mouse
Original Format of Ab: IgG1
-
纯化方法
- Protein A affinity purified
-
免疫原
- This antibody was raised by immunising BALB/c mice with TAG-72 purified from LS-174T human carcinoma xenograft.
-
亚型
- IgG1 kappa
-
-
anti-TAG-72 (Minretumomab Biosimilar) antibody
适用: 人 FACS, IHC, RIA, WB 宿主: 兔 Chimeric unconjugated Recombinant Antibody
-
-
应用备注
- The reactivity of this antibody with colon cancer extract and purified TAG-72 has been confirmed in solid-phase radioimmunoassays, and its reactivity with formalin-fixed carcinoma tissue sections confirmed in immunoperoxidase studies (Muraro et al, 1988). In flow cytometric analysis of freshly-isolated human carcinoma cells, this antibody reacts more strongly than the anti-TAG-72 MAb B72.3 (Muraro et al, 1988). Equally, flow cytometric analyses using this antibody have revealed that TAG-72 is expressed by certain haematopoietic cell lines (Nicolet et al, 1997). In western blot analysis, this antibody reacts with TAG-72 (Muraro et al, 1988). A humanised version of this antibody has been shown to be safe and sensitive in detecting recurrent colorectal carcinomas in radioimmunoguided surgery (Agnese et al, 2004), while radioimmunotherapy with an iodine-131-conjugated antibody has been shown to have a significant therapeutic effect on metastatic colon carcinoma in Phase I trials (Divgi et al, 1995).
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- PBS with 0.02 % Proclin 300.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- TAG-72 (Minretumomab Biosimilar)
-
背景
- CA 72-4, Tumor-associated antigen 72, TAG72, Tumor-associated glycoprotein 72
抗原
-
You are here:
